Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism

Journal of the American Society of Nephrology

Volumn 16, Issue 4, 2005, Pages 929-938

  Sanchez, Cheryl P ^a   He, Yu Zhu ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CELL NUCLEUS ANTIGEN; CYCLINE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RECEPTOR 1; PHOSPHORUS; SODIUM CHLORIDE; SOMATOMEDIN BINDING PROTEIN 1; VITAMIN D; CALCIUM CHANNEL STIMULATING AGENT; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DISEASE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INTERMITTENT THERAPY; HYPERPARATHYROIDISM; KIDNEY FAILURE; MALE; MORPHOMETRICS; NEPHRECTOMY; NONHUMAN; OPTIMAL DRUG DOSE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STAINING; ANIMAL; BLOOD; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; GROWTH; GROWTH PLATE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SECONDARY HYPERPARATHYROIDISM; SPRAGUE DAWLEY RAT;

ANIMALS; CALCITRIOL; CALCIUM CHANNEL AGONISTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GROWTH; GROWTH HORMONE; GROWTH PLATE; HYPERPARATHYROIDISM, SECONDARY; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE; MALE; PARATHYROID HORMONE; PHOSPHORUS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 24344508210     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2003100878     Document Type: Article

References (28)

1. Wuhl E, Haffner D, Nissel R, Schaefer F, Mehls O: Short dialyzed children respond less to growth hormone than patients prior to dialysis. Pediatr Nephrol 10: 294-298, 1996
2. 2 in signal transduction by growth hormone. Pediatr Nephrol 14: 550-557, 2000
3. Gevers EF, Milne J, Robinson ICAF, Loveridge N: Single cell enzyme activity and proliferation in the growth plate: Effects of growth hormone. J Bone Miner Res 11: 1103-1111, 1996
4. Kassem M, Blum W, Ristelli J, Mosekilde L, Eriksen EF: Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 52: 222-226, 1993
5. Klaus G, Meinhold-Heerlein R, Milde P, Ritz E, Mehls O: Effect of vitamin D on growth cartilage cell proliferation in vitro. Pediatr Nephrol 5: 461-466, 1991
6. Mehls O, Knoller N, Oh J, Wesch H, Wunsche B, Schmitt CP: Daily but not pulse calcitriol therapy improves growth in experimental uremia. Pediatr Nephrol 14: 658-663, 2000
7. Ardissino G, Schmitt CP, Testa S, Claris-Appiani A, Mehls O: Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. Pediatr Nephrol 14: 664-668, 2000
8. Schmitt CP, Ardissino C, Testa S, Claris-Appiani A, Mehls O: Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 18: 440-444, 2003
9. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB: Diminished linear growth during intermittent calcitriol therapy in children undergoing Ccpd. Kidney Int 53: 205-211, 1998
10. Goodman WG, Ramirez JA, Belin TR, Choi Y, Gales B, Segre GV, Salusky IB: Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46: 1160-1166, 1994
11. Sanchez CP, Salusky IB, Kuizon BD, Abdella P, Juppner H, Gales B, Goodman WG: Growth of long bones in renal failure: Roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54: 1879-1887, 1998
12. Sanchez CP, He Y-Z: Alterations in the growth plate cartilage of rats with renal failure receiving corticosteroid therapy. Bone 30: 692-698, 2002
13. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A: A novel mechanism for skeletal resistance in uremia. Kidney Int 58: 753-761, 2000
14. Schmitt CP, Hessing S, Oh J, Weber L, Ochlich P, Mehls O: Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats. Kidney Int 57: 1484-1492, 2000
15. 5) system in osteoblast-like cells. J Biol Chem 277: 34879-34884, 2002
16. Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R: Impaired Jak-Stat signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 108: 467-475, 2001
17. 3 on receptor expression and growth stimulation in rat growth plate chondrocytes. Kidney Int 53: 1152-1161, 1998
18. Jensen S, Madsen M, Lukas J, Binderup L, Bartek J: Inhibitory effects of 1α,25-dihydroxyvitarnin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol 15: 1370-1380, 2001
19. waf1 and TGF- mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 60: 2109-2117, 2001
20. 3 in experimental renal hyperparathyroidism. Kidney Int 44: 1259-1265, 1993
21. Amizuka N, Davidson D, Liu H, Valverde-Franco G, Chai S, Maeda T, Ozawa H, Hammond V, Ornitz D, Goltzman D, Henderson J: Signalling by fibroblast growth factor receptor 3 and parathyroid hormone-related peptide coordinate cartilage and bone development. Bone 34: 13-25, 2004
22. G380r transgenic mice. Hum Mol Genet 9: 249-258, 2000
23. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P: Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84: 911-921, 1996
24. Nifuji A, Noda M: Coordinated expression of noggin and bone morphogenetic proteins (Bmps) during early skeletogenesis and induction of noggin expression by Bmp-7. J Bone Miner Res 14: 2057-2066, 1999
25. Wu LNY, Ishikawa Y, Genge BR, Sampath TK, Wuthier RE: Effect of osteogenic protein-1 on the development and mineralization of primary cultures of avian growth plate chondrocytes: Modulation by retinoic acid. J Cell Biochem 67: 498-513, 1997
26. Lund RJ, Davies MR, Brown AJ, Hruska KA: Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol 15: 359-369, 2004
27. Gonzalez EA, Lund RJ, Martin KJ, McCartney JE, Tondravi MM, Sampath TK, Hruska KA: Treatment of a murine model of high-turnover renal osteodystrophy by exogenous Bmp-7. Kidney Int 61: 1322-1331, 2002
28. Dyck MV, Gyssels A, Proesmans W, Nijs J, Eeckels R: Growth hormone treatment enhances bone mineralisation in children with chronic renal failure. Eur J Pediatr 160: 359-363, 2001